Hemostemix (HMTXF, $0.07) was one of top quarterly gainers, jumping +14 to $0.07 per share. A.I.dvisor analyzed 844 stocks in the Biotechnology Industry over the last three months, and discovered that of them (4) charted an Uptrend while of them (5) trended down.